scholarly journals Selection of basal medium for culturing human umbilical cord mesenchymal stem cells in combination with human platelet lysate

2020 ◽  
Author(s):  
Lingjuan Wang ◽  
Chunxiang Liu ◽  
Huiying Lu ◽  
JUN YAN ◽  
Yi Zhang

Abstract Background Different basal media have very different effects on cell growth, proliferation and differentiation potential of cultured human umbilical cord mesenchymal stem cell (hUC-MSC). This issue has not gotten enough research. The goal of this study is to select high safety and low cost basal media for hUC-MSC, which performs best in combination with commercial human platelet lysate product for cell proliferation and differentiation functions, especially suitable for high-passage hUC-MSC cultures. Methods Three different basal media were combined with 5% UltraGROGAdvanced to culture P0 to P8 passage hUC-MSC. Cell morphology, cell expansion ratio, proliferation, differentiation and cell surface markers were examined and analyzed in order to draw conclusions. Results When observing the same passage under different culture systems, the number of cells obtained in MSCBM and α-MEM were higher than that cultured in IMDM (0.01 < P < 0.05). The results between MSCBM and α-MEM were not significantly different (P > 0.05). Combining growth curve measurement and cell doubling time calculation, it was found that the cell proliferation functions of the three culture media were ranked as MSCBM, α-MEM and IMDM from high to low. The P8 cells cultured in different media all yield good clonal formation, and also all differentiated well. The number of cells differentiated into osteoblasts and chondrocytes cultured in different media was not significantly different (P > 0.05), while the number of adipocyte differentiation in MSCBM and α-MEM cultures were significantly higher than that of IMDM culture (0.01 < P < 0.05). The cells in all cultures uniformly express high levels of MSC surface markers CD73, CD90, CD105, and negatively express CD34, CD45. Conclusions Taking all indicators into consideration, we conclude that the culture system of MSMBM supplemented with 5% UltraGROGAdvanced is the best for culturing hUC-MSC withα-MEM follows right after. This study revealed the importance of basal media in MSC cultures, and offer guidance on their selective use.

2021 ◽  
Vol 16 (1) ◽  
pp. 71-85
Author(s):  
Vafa Meftahpour ◽  
Somaiyeh Malekghasemi ◽  
Amir Baghbanzadeh ◽  
Ali Aghebati-Maleki ◽  
Ramin Pourakbari ◽  
...  

Human platelet lysate has attracted much interest from many researchers as it is growth-factor rich for cell expansion, which is employed as a new therapeutic strategy. Not only are human platelet lysates used for cell therapy, but they are also used for the completion of basal media in mesenchymal stem cell cultures. Due to the presence of a large number of growth factors, platelet lysates have potential roles in wound healing, treatment of ocular graft-versus-host disease, osteoarthritis, Parkinson’s disease, tendon regeneration, infertility, androgenetic alopecia, nerve repair and regenerative tissue, such as bone regeneration. In this review, we summarize that platelet lysates could be valuable candidates for the treatment of a variety of diseases in regenerative medicine.


Transfusion ◽  
2020 ◽  
Vol 60 (10) ◽  
pp. 2348-2358
Author(s):  
Marie‐Ève Rhéaume ◽  
Pascal Rouleau ◽  
Tony Tremblay ◽  
Isabelle Paré ◽  
Lionel Loubaki

Cytotherapy ◽  
2013 ◽  
Vol 15 (4) ◽  
pp. S17
Author(s):  
V. Pfarrhofer ◽  
K. Höller ◽  
D. Stübl ◽  
K. Plöderl ◽  
S. Hennerbichler-Lugscheider ◽  
...  

Author(s):  
Guilian Liao ◽  
Yan Liao ◽  
Duanduan Li ◽  
Zeqin Fu ◽  
Shiduo Wu ◽  
...  

Mesenchymal stromal cells (MSCs) show potential for treating preclinical models of newborn bronchopulmonary dysplasia (BPD), but studies of their therapeutic effectiveness have had mixed results, in part due to the use of different media supplements for MSCs expansion in vitro. The current study sought to identify an optimal culture supplement of umbilical cord-derived MSCs (UC-MSCs) for BPD therapy. In this study, we found that UC-MSCs cultured with human platelet lysate (hPL-UCMSCs) were maintained a small size from Passage 1 (P1) to P10, while UC-MSCs cultured with fetal bovine serum (FBS-UCMSCs) became wide and flat. Furthermore, hPL was associated with lower levels of senescence in UC-MSCs during in vitro expansion compared with FBS, as indicated by the results of β-galactosidase staining and measures of senescence-related genes (CDKN2A, CDKN1A, and mTOR). In addition, hPL enhanced the proliferation and cell viability of the UC-MSCs and reduced their doubling time in vitro. Compared with FBS-UCMSCs, hPL-UCMSCs have a greater potential to differentiate into osteocytes and chondrocytes. Moreover, using hPL resulted in greater expression of Nestin and specific paracrine factors (VEGF, TGF-β1, FGF2, IL-8, and IL-6) in UC-MSCs compared to using FBS. Critically, we also found that hPL-UCMSCs are more effective than FBS-UCMSCs for the treatment of BPD in a rat model, with hPL leading to improvements in survival rate, lung architecture and fibrosis, and lung capillary density. Finally, qPCR of rat lung mRNA demonstrated that hPL-UCMSCs had lower expression levels of inflammatory factors (TNF-α and IL-1β) and a key chemokine (MCP-1) at postnatal day 10, and there was significant reduction of CD68+ macrophages in lung tissue after hPL-UCMSCs transplantation. Altogether, our findings suggest that hPL is an optimal culture supplement for UC-MSCs expansion in vitro, and that hPL-UCMSCs promote lung repair in rat BPD disease.


Sign in / Sign up

Export Citation Format

Share Document